Latest News

Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases

Scientists report an advance toward "structure-based drug design," with the potential to delay or treat Alzheimer's disease, Parkinson's disease, type II diabetes, ALS (also known as Lou Gehrig's disease) and many other degenerative diseases.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Genetic dysfunction connected to hydrocephalus discovered by international research team

  • Good news for aging population: Incidence of stroke in elderly has dropped by 40% over last 20 years

  • You should talk to strangers: Doing so increases positive experience, study shows

  • High rates of violence suffered by unstably housed women in San Francisco

  • Mothers of Children with Autism Benefit From Peer-Led Intervention

  • Children's impulsive behaviour is related to brain connectivity

  • Innovative system anticipates driver fatigue in the vehicle to prevent accidents

  • Rigid connections: Molecular basis of age-related memory loss explained

  • Low strength brain stimulation may be effective for depression

  • High school lacrosse players at risk for concussions, other injuries, study finds

  •